1. (1) HDC product manufacturers must, in addition to labeling requirements under the Act, label each HDC product with the following:

   1. (a) Batch number;
   2. (b) Name and address of the HDC product manufacturer or distributor;
   3. (c) A list of all ingredients, ordered by weight, including direct and indirect additives;
   4. (d) A separate allergen statement, stating common name of allergen, if product contains any of the following ingredients: eggs; fish; milk; tree nuts; peanuts; sesame; shellfish; soy; or wheat;
   5. (e) A QR code that when scanned links the viewer to COA testing results conducted under this chapter. A QR code that does not link to the landing page designated by the testing laboratory as registered with the department shall be considered invalid and a violation of this rule;
   6. (f) Serving size of the product and the total number of servings per package of the product (applicable only for ingestible HDC products); and,
   7. (g) The numerical count, net weight, or net volume of the product per package. Net weight and net volume must be reported in both standard and metric measurements.

2. (2) Warning statements. HDC product manufacturers must include the following warning statement(s), printed in at least six-point, easily legible font on the label panel of associated HDC products, and shall be conspicuous and in distinct contrast (e.g. by typography, layout, color, or embossing) to other information on the package.

   1. (a) For all HDC products.

      1. 1. “Warning: Keep out of reach of children. Must be 21 or older to possess or consume. May be harmful to those who are pregnant or breastfeeding. May impair ability to drive or operate machinery. May contain unidentified substances that are harmful or toxic. This product is not approved by FDA for cure, mitigation, treatment, or prevention of any disease.”
      2. 2. The word “Warning” must be printed in bold font, all capital letters.

   2. (b) Additional warning statement for inhalable HDC products.

      1. 1. “Warning: Inhalation of cannabis smoke has been associated with lung injury.”
      2. 2. The word “Warning” must be printed in bold font, all capital letters.
3. (3) A person shall not manufacture or distribute any HDC product labeled as a dietary supplement.

Authority: T.C.A. §§ 4-3-203 and 43-27-211. Administrative History: New rules filed September 27, 2024; effective December 26, 2024. CANNABINOID PRODUCTS